| High tumor mutation burden predicts better efficacy of immunotherapy: a pooled analysis of 103078 cancer patients | |
| Cao, Dedong; Xu, Huilin; Xu, Ximing; Guo, Tao; Ge, Wei | |
| 刊名 | ONCOIMMUNOLOGY
 |
| 2019 | |
| 卷号 | 8期号:9 |
| 关键词 | Tumor mutation burden immunotherapy prognosis survival cancer |
| ISSN号 | 2162-402X |
| DOI | 10.1080/2162402X.2019.1629258 |
| URL标识 | 查看原文 |
| 收录类别 | SCIE |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4233526 |
| 专题 | 武汉大学 |
| 推荐引用方式 GB/T 7714 | Cao, Dedong,Xu, Huilin,Xu, Ximing,et al. High tumor mutation burden predicts better efficacy of immunotherapy: a pooled analysis of 103078 cancer patients[J]. ONCOIMMUNOLOGY,2019,8(9). |
| APA | Cao, Dedong,Xu, Huilin,Xu, Ximing,Guo, Tao,&Ge, Wei.(2019).High tumor mutation burden predicts better efficacy of immunotherapy: a pooled analysis of 103078 cancer patients.ONCOIMMUNOLOGY,8(9). |
| MLA | Cao, Dedong,et al."High tumor mutation burden predicts better efficacy of immunotherapy: a pooled analysis of 103078 cancer patients".ONCOIMMUNOLOGY 8.9(2019). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论